Establishment of immortalized rabbit bone marrow mesenchymal stem cells and a preliminary study of their osteogenic differentiation capability
Background A stable and standardized source of mesenchymal stem cells is a prerequisite for bone repair tissue engineering research and application. We aimed to establish a stable cell line of bone marrow mesenchymal stem cells from New Zealand rabbits and explore their osteogenic differentiation ca...
Saved in:
Published in | Animal models and experimental medicine Vol. 7; no. 6; pp. 824 - 834 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.12.2024
Laboratory of Animal Center,Chongqing Medical University,Chongqing,China%Laboratory of Animal Center,Southwest University,Chongqing,China%Stomatological Hospital of Chongqing Medical University,Chongqing,China John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
A stable and standardized source of mesenchymal stem cells is a prerequisite for bone repair tissue engineering research and application. We aimed to establish a stable cell line of bone marrow mesenchymal stem cells from New Zealand rabbits and explore their osteogenic differentiation capacity.
Methods
Primary rabbit bone marrow mesenchymal stem cells (RBMSCs) were isolated and immortalized via retroviral expression of SV40 Large T antigen (LTA). To assess the osteogenic differentiation capacity of the cells in vitro, we studied the alkaline phosphatase (ALP) expression level and calcium deposition in bone morphogenetic protein 9 (BMP9)‐induced immortalized cells using ALP staining and quantification, as well as alizarin red staining. Ectopic bone formation by the cells was assessed using micro‐computed tomography (μCT) and histological examination.
Results
The immortalized cell line we established using SV40 LTA, which we termed iRBMSCs, was non‐tumorigenic and maintained long‐term proliferative activity. We further discovered that BMP9 (MOI = 30) effectively induced the osteogenic differentiation capacity of iRBMSCs in vitro, and there was a synergy with GelMA hydrogel in inducing osteogenic differentiation of the iRBMSCs in vivo.
Conclusion
We confirmed that iRBMSCs are promising as a stable cell line source for bone defect repair engineering.
Primary rabbit bone marrow mesenchymal stem cells (RBMSCs) were isolated and immortalized via retroviral expression of SV40 Large T antigen. We studied the ALP expression level and calcium deposition in bone morphogenetic protein 9 (BMP9)‐induced immortalized cells in vitro. There was a synergy with BMP9 and GelMA hydrogel in inducing osteogenic differentiation of the iRBMSCs in vivo. We confirmed that iRBMSCs are promising as a stable cell line source for bone defect repair engineering. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 2576-2095 2096-5451 2576-2095 |
DOI: | 10.1002/ame2.12513 |